3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
17
Gastrointestinal Stromal Tumors
10
Neoplasms
5
Neoplasm Metastasis
4
Multiple Myeloma
4
Kidney Neoplasms
4
Urologic Neoplasms
2
Thyroid Neoplasms
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Osteosarcoma
2
Meningioma
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Kidney Diseases
2
Gastrointestinal Neoplasms
2
Carcinoma, Hepatocellular
2
Carcinoma
2
Adenoma, Islet Cell
2
Uveal Melanoma
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thymoma
1
Stomach Neoplasms
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Rectal Neoplasms
1
Primary Disease: Unresectable or Metastatic Renal Cell Carcinoma Focus of the Study:PFS Assessed by IRC Per RECIST 1.1
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Interventions
nirogacestat
5
Specimen Handling
3
Cryosurgery
3
X-Rays
2
Phantoms, Imaging
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Blood Specimen Collection
2
trifluridine tipiracil drug combination
1
Oxaliplatin
1
Leucovorin
1
Ipilimumab
1
Imatinib Mesylate
1
High-Intensity Focused Ultrasound Ablation
1
Fluorouracil
1
Embolization, Therapeutic
1
Electrochemotherapy
1
E-7386
1
Doxorubicin
1
Cyclophosphamide
1
Cryotherapy
1
CTLA-4 Antigen
1
Bone Density
1
Bleomycin
1
Biopsy
1
Bevacizumab
1
Absorptiometry, Photon
1
4-hydroxy-N-desmethyltamoxifen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Desmoid Tumors
×
Sunitinib
×
1 year
×
Clear all
No trials found.